- Created on 16 December 2011
- Written by Srinivasan (Vasan) Yegnasubramanian
Our multidisciplinary team used both laboratory and epidemiological approaches to uncover a potential application of the heart drug digoxin in prostate cancer prevention and/or therapy. Read about it in the April issue of Cancer Discovery. This work has been covered by several press sources, e.g., ScienceDaily (Apr. 3, 2011): Heart Drug Cuts Prostate Cancer Risk, Holds Potential for Therapeutic Use.